Tegus was advised on the transaction by teams at Latham & Watkins and Davies Ward Phillips & Vineberg. Osler, Hoskin & Harcourt LLP advised Canalyst. Tegus,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented InBrace in the transaction. Horizon Technology Finance Corporation (NASDAQ: HRZN) (Horizon) has announced the close of a US$45 million growth facility...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Ardelyx, Inc. in the transaction in the transaction. Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Rhythm Pharmaceuticals, Inc. in the transaction, while Morgan, Lewis & Bockius acted as legal advisor to HealthCare Royalty. Rhythm Pharmaceuticals, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Brilliant Earth in the transaction. Brilliant Earth is a digitally native, omnichannel fine jewelry company and a global leader in ethically sourced fine...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised ParaFi Capital in the transaction. ZenLedger, a global leader in cryptocurrency data analysis, accounting, and tax, announced the close of its US$15...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Lateral Investment Management on the transaction. FirstClose, a leading property and borrower data intelligence provider, has closed a US$35 million funding round...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Ouster, Inc. on the deal. Ouster, Inc., a leading lidar technology developer, executed an up to US$50 million structured debt facility from Hercules...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised BridgeBio on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, has entered into...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Kennedy Lewis Investment Management LLC in the transaction. Impulse Dynamics, a global medical device company a medical device company organized in Curacao...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Cipher Mining in the transaction. Alborz LLC, a joint venture affiliate of Cipher Mining Inc. (NASDAQ: CIFR) and WindHQ LLC, has announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented HilleVax, while Davis Polk advised the joint book-running managers in the IPO. HilleVax, Inc., a clinical-stage biopharmaceutical company focused on developing and...
You must be a Standard 1 Year member to access this content.
